These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Experiences to date with oral gold therapy]. Zeidler H Wien Klin Wochenschr Suppl; 1984; 156():22-7. PubMed ID: 6442052 [TBL] [Abstract][Full Text] [Related]
6. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report. Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485 [TBL] [Abstract][Full Text] [Related]
8. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety]. Batlle Gualda E Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899 [No Abstract] [Full Text] [Related]
9. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis. Wessel J; Davis P J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690 [No Abstract] [Full Text] [Related]
10. Gold in rheumatoid arthritis; the past, present and future. Proceedings of a symposium held in Copenhagen, April 15-16, 1983. Scand J Rheumatol Suppl; 1983; 51():1-139. PubMed ID: 6426042 [No Abstract] [Full Text] [Related]
11. Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis. Furst DE Pharmacotherapy; 1983; 3(5):284-98. PubMed ID: 6417628 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis. Edelman J; Davis P; Owen ET J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032 [TBL] [Abstract][Full Text] [Related]
13. Gold concentrations and toxicity during oral gold treatment with auranofin. Sharma RP; Smillie J; Palmer DG Pharmacology; 1985; 30(2):115-20. PubMed ID: 3919401 [TBL] [Abstract][Full Text] [Related]
14. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis. Davis P; Menard H; Thompson J; Harth M; Beaudet F J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393 [TBL] [Abstract][Full Text] [Related]
15. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study. Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483 [TBL] [Abstract][Full Text] [Related]
16. Oral chrysotherapy in rheumatoid arthritis: auranofin. Cleveland Clinic experience and literature review. Mazanec DJ; Segal AM; Mackenzie AH; Lippert M Cleve Clin Q; 1985; 52(2):123-8. PubMed ID: 3928200 [No Abstract] [Full Text] [Related]
17. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate. Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711 [TBL] [Abstract][Full Text] [Related]
18. Placebo-controlled comparison of oral gold with injectable gold in early rheumatoid arthritis. Davies J; Bacon PA; Hall ND; Ring EF Clin Rheumatol; 1984 Dec; 3(4):553-4. PubMed ID: 6441670 [No Abstract] [Full Text] [Related]
19. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis. Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923 [TBL] [Abstract][Full Text] [Related]